Filing Details

Accession Number:
0001140361-10-051161
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-12-23 12:23:57
Reporting Period:
2010-12-22
Filing Date:
2010-12-23
Accepted Time:
2010-12-23 12:23:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401782 Mark Wood C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-12-22 937 $14.39 15,180 No 4 M Direct
Common Stock Acquisiton 2010-12-22 625 $17.33 15,805 No 4 M Direct
Common Stock Acquisiton 2010-12-22 834 $17.54 16,639 No 4 M Direct
Common Stock Acquisiton 2010-12-22 83 $17.86 16,722 No 4 M Direct
Common Stock Disposition 2010-12-22 2,479 $28.21 14,243 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2010-12-22 937 $0.00 937 $14.39
Common Stock Stock Option (right to buy) Disposition 2010-12-22 625 $0.00 625 $17.33
Common Stock Stock Option (right to buy) Disposition 2010-11-22 834 $0.00 834 $17.54
Common Stock Stock Option (right to buy) Disposition 2010-12-22 83 $0.00 83 $17.86
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
115,190 2009-11-12 2019-05-11 No 4 M Direct
114,565 2007-12-07 2017-06-06 No 4 M Direct
113,731 2007-05-20 2016-11-19 No 4 M Direct
113,648 2009-06-17 2018-12-16 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 105-1 Trading plan executed on August 20, 2010.
  2. The price in Column 4 is a weighted average price. The prices actually received ranged from $28.09 to $28.33. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Original option grant vests 6/48th on November 1, 2009 and 1/48th each on the 12th of each month thereafter.
  4. Original option grant vests 6/48th on December 7, 2007 and 1/48th each on the 7th of each month thereafter.
  5. Original option grant vests 6/48th on May 20, 2007 and 1/48th each on the 29th of each month thereafter.
  6. Original option grant vests 6/48th on June 17, 2009 and 1/48th each on the 17th of each month thereafter.